The #LancetGateEffect Is Taking Names Before Kicking Ass – Please Contribute To The List

Things are happening faster than I expected.

Check this out.

We need to contribute to this effort.

Please dig up EVERY LINK that you can find of anti-HCQ and post it here. Be sure to include a description, including WHO exactly is referenced, to save people time when they go through comments.

Also, I highly recommend SCREENSHOTS, ARCHIVES, etc., and please provide LINKS to any screenshots or archives.

I would love for this blog to be a major contributor to the list of WHO (pun NOW intended) is responsible for anti-HCQ treachery.

Even if somebody is just repeating propaganda, it may help lead back to the source.

Leads are fine, as well as PROOFS.


0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

This is good by Todaro. Gilead influenced Lancet article, is behind squashing HCQ, in order to promote remdecivir.
Gilead’s influence over the process of clinical investigation and approval of therapeutics is undeniable. A direct threat to remdesivir, hydroxychloroquine has likely been in Gilead’s crosshairs for months.
Gilead: Twenty-one billion reasons to discredit hydroxychloroquine

Fauci promotes remdecivir. What is his connection to Gilead?
Remember from early Covid threads. Gilead and Chyna. They both have patents on remdecivir.


Canadian CBC posted this Anti-HCQ video on July 5, 2020.
Pure propaganda!


Washington Examiner article about Dr. Harvey Risch and how Fauci and others have derided him for his pro-HCQ position.
Link in this tweet:


DC Examiner article:
Hydroxychloroquine works in high-risk patients, and saying otherwise is dangerous – by Harvey Risch | August 12, 2020 10:29 AM
In the article, Dr Hirsch mentions the FDA gets 1/3 of its funding from drug companies….
The fact that the FDA – a government agency – gets 1/3 of its funding from drug companies is wrong and dangerous to the public – because it means private interests/profits may influence FDA decisions on approvals of drugs.


GA/FL the rest of your posts on this are worth repeating here…

Dr. Harvey Risch from the Washington Examiner article linked above:
“I reiterate: If doctors, including any of my Yale colleagues, tell you that scientific data show that hydroxychloroquine does not work in outpatients, they are revealing that they can’t tell the difference between low-risk patients who are not generally treated and high-risk patients who need to be treated as quickly as possible. Doctors who do not understand this difference should not be treating COVID-19 patients.”

Dr. Risch continues:
“What about medication safety? On July 1, the FDA posted a “black-letter warning” cautioning against using hydroxychloroquine “outside of the hospital setting,” meaning in outpatients. But on its website just below this warning, the FDA stated that the warning was based on data from hospitalized patients. To generalize and compare severely ill patients with COVID-induced pneumonia and possibly heart problems to outpatients is entirely improper.
In fact, the FDA has no information about adverse events in early outpatient use of hydroxychloroquine. The only available systematic information about adverse events among outpatients is discussed in my article in the American Journal of Epidemiology, where I show that hydroxychloroquine has been extremely safe in more than a million users.
It is a serious and unconscionable mistake that the FDA has used inpatient data to block emergency use petitions for outpatient use. Further, already back in March, the FDA approved the emergency use of hydroxychloroquine for hospitalized patients, for whom it is demonstrably less effective than for outpatients. If hydroxychloroquine satisfied the FDA criteria for emergency inpatient use in March, it should more than satisfy those criteria now for outpatient use, where the evidence is much stronger.
I can only speculate about the cause of the FDA’s recalcitrance. Hydroxychloroquine is an inexpensive, generic medication. Unlike certain profit-generating, patented medications, which have been promiscuously touted on the slimmest of evidence, hydroxychloroquine has no natural financial constituency. No one will get rich from it.
Further, it seems quite possible that the FDA, a third of whose funding comes from drug companies, is under intense pressure from those companies to be extremely conservative in its handling of hydroxychloroquine. If hydroxychloroquine is used widely and comes to be recognized as highly effective, the markets for expensive and patented COVID-19 medications, including intravenous drugs that can only be used in the hospital, will shrink substantially.”


They CHEAT to win.

Rodney Short

Neil Cavuto will kill you if he had his way, anything that is orange man bad Cavuto pushes


Graft.comment image


What do you expect from a university that was founded by slave owners?

Plain Jane

Two cardiologists in the family suggested something pretty cool and helpful to others also. If you think you may have had wuflu and recovered, but don’t want to get tested, go to donate blood.
They check for all the antibodies.

Plain Jane

That is exactly I posted this where you would see it Wolfie. God bless and nighty night.

[…] The #LancetGateEffect Is Taking Names Before Kicking Ass – Please Contribute To The List […]